Biotech Showcase
An all-inclusive life science conference
Save the date for next yearJanuary 12–14, 2026 | San Francisco, CA
Log in to partneringONE
Menu
Log in to partneringONE
Biopharma and Tech Innovators – Summer 2020
By Xconomy and EBD GroupShareshare

The recent rapid progression of drug development, diagnostic tests, and healthcare tools have pushed us into new territory that was unthinkable – or even unknown – just a decade ago. While sectors beg for bailouts, biopharma has remained buoyant and resilient in the face of COVID-19.

Biopharma and Tech Innovators – Summer 2020

Download Xconomy and EBD Group’s new special report Biopharma and Tech Innovators – Summer 2020 to learn more about the cutting-edge companies behind these innovations that are disrupting the sector and revolutionizing the healthcare landscape.

Download

What’s inside:

  • Company profiles with insider info about their latest advancements
  • How to secure biotech deals
  • Special sections on drug discovery and development, immunology and oncology, emerging therapies and startups

Biopharma and Tech Innovators

Innovation
Drug development
BIO-Europe Spring

Related news

BIO-Europe Spring

Mobilizing a Bio-Revolution

At the BIO-Europe Spring Opening Plenary “In the thick of it: Navigating beyond vaccine discovery”, Informa’s Eleanor Malone hosted a discussion with three leading authorities in biotech: Bayer’s Marianne De Backer, Pfizer’s Monika Vnuk, and Medicxi’s Francesco De Rubertis.
Innovation

Interview: Promoting prosperity in the life science sectors of China and the UK

In this exclusive interview, Her Majesty’s Trade Commissioner for China at the Department for International Trade, John Edwards, discusses how China’s healthcare and life sciences markets are growing rapidly and are driven by increased demand and changes to regulations, plus much more.
Drug Development

Interview: Importance of diversity and partnering in global life sciences

ATLATL Innovation Cluster (IC) in the heart of Zhangjiang Pharma Valley. Its Founder and CEO, Dr. P.C. Zhu, designed it to be a launchpad for high-potential life sciences in China. In this interview with EBD Group he discusses the opportunities ATLATL provides and the importance of partnering in the life science industry.
Drug Development

Video Interview - Johnson & Johnson’s approach to external innovation

William N. Hait, MD, PhD, Global Head at Johnson & Johnson External Innovation gives an exclusive interview to Lucie Ellis, Executive Editor of In Vivo, Pharma Intelligence, ahead of ChinaBio® Partnering Forum Digital.